Daiwa Securities Group’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-346
Closed -$1K 1300
2025
Q4
$1K Buy
+346
New +$1.53K ﹤0.01% 1346
2023
Q4
Sell
-144
Closed 1353
2023
Q3
$0 Hold
144
﹤0.01% 1310
2023
Q2
$0 Hold
144
﹤0.01% 1334
2023
Q1
$0 Hold
144
﹤0.01% 1309
2022
Q4
$1K Hold
144
﹤0.01% 1274
2022
Q3
$1K Hold
144
﹤0.01% 1291
2022
Q2
$2K Hold
144
﹤0.01% 1241
2022
Q1
$2K Hold
144
﹤0.01% 1253
2021
Q4
$7K Hold
144
﹤0.01% 1169
2021
Q3
$10K Buy
144
+81
+129% +$5.86K ﹤0.01% 1141
2021
Q2
$5K Buy
63
+26
+70% +$1.72K ﹤0.01% 1073
2021
Q1
$2K Buy
37
+7
+23% +$380 ﹤0.01% 1143
2020
Q4
$1K Buy
+30
New +$1.18K ﹤0.01% 1180

Other funds holding NBP

Daiwa Securities Group's NBP Position: Q1 2026 in Review

Daiwa Securities Group sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q1 2026, closing a stake of 346 shares — an estimated $1K sold.

Daiwa Securities Group first reported a position in NBP in Q4 2020 and held it in 13 quarters. The position peaked at $10K in Q3 2021. 48 funds tracked by Wall St. Rank hold NBP as of Q1 2026.

  • Daiwa Securities Group reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q1 2026 after selling out during the quarter.
  • Daiwa Securities Group sold 346 NovaBridge Biosciences American Depositary Shares shares in Q1 2026, an estimated $1K.
  • Daiwa Securities Group first reported a position in NovaBridge Biosciences American Depositary Shares in Q4 2020 and held it in 13 quarters.
  • Daiwa Securities Group's NovaBridge Biosciences American Depositary Shares position peaked at $10K in Q3 2021.
  • 48 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q1 2026.

Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.